Bausch Health (NYSE: BHC) director receives 5,946 RSUs for board service

Rhea-AI Filing Summary

Bausch Health Companies Inc. director Sandra Leung received an equity compensation award in the form of Restricted Share Units for her board service for the quarter ending March 31, 2026. She acquired 5,946 common shares at a deemed price of $5.40 per share, bringing her direct holdings to 44,354 common shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider LEUNG SANDRA

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares, No Par Value	5,946	$5.40	$32K

Holdings After Transaction: Common Shares, No Par Value — 44,354 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 5,946 units Grant value per share: $5.40 per share Shares owned after grant: 44,354 shares

3 metrics

RSUs granted 5,946 units Restricted Share Units issued for board service quarter ending March 31, 2026

Grant value per share $5.40 per share Deemed transaction price for each common share underlying the RSUs

Shares owned after grant 44,354 shares Total direct common share holdings following the RSU award

Key Terms

Restricted Share Units, contingent right, in lieu of cash compensation

3 terms

Restricted Share Units financial

"Reflects Restricted Share Units issued in lieu of cash compensation"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

contingent right financial

"each representing a contingent right to receive one common share"

in lieu of cash compensation financial

"issued in lieu of cash compensation in connection with the Reporting Person's service"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LEUNG SANDRA

(Last) (First) (Middle)

400 SOMERSET CORPORATE BLVD.

(Street)

BRIDGEWATER NEW JERSEY 08807

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bausch Health Companies Inc. [ BHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	03/31/2026		A		5,946(1)	A	$5.4	44,354	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending March 31, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer.

	/s/ Brianna M. Dorsi attorney-in-fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did BHC director Sandra Leung report?

Sandra Leung reported receiving 5,946 Restricted Share Units of Bausch Health Companies Inc. as equity compensation. Each unit represents a contingent right to one common share, issued instead of cash for her board service for the quarter ending March 31, 2026.

Was the BHC Form 4 transaction a purchase or a grant?

The BHC Form 4 transaction was a grant, not an open-market purchase. Leung received 5,946 Restricted Share Units as compensation for her board service, classified as a grant, award, or other acquisition rather than a discretionary stock purchase.

How many Bausch Health shares does Sandra Leung hold after this grant?

After this grant, Sandra Leung holds 44,354 common shares of Bausch Health Companies Inc. This total reflects her direct ownership following the award of 5,946 Restricted Share Units for the quarter ending March 31, 2026.

What are the terms of the Restricted Share Units reported by BHC?

The Restricted Share Units reported by BHC each represent a contingent right to receive one common share with no par value. They were issued instead of cash compensation for Sandra Leung’s service on the board during the quarter ending March 31, 2026.

At what price were the BHC Restricted Share Units valued in this Form 4?

The 5,946 Restricted Share Units granted to Sandra Leung were valued at $5.40 per unit. This price is used in the filing to indicate the transaction value per common share underlying each Restricted Share Unit granted as compensation.